Others

Marksans Pharma Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

| Updated on March 07, 2019 Published on March 07, 2019

US FDA Audit update
Dear Sirs,

This is to inform that the U.S. FDA has concluded inspection of Companys Goa facility. The inspection of the facility took place between 25th February to 6th March 2019, resulting in a Form 483 with eight observations. None of these observations are considered either critical or repetitive in nature. Company is highly confident of closing these expeditiously and remains commited to global standards of quality & compliance. The site will continue to supply to the US markets all approved ANDAs. This inspection will help Company to received pending ANDAs approval alredy filed by it.


This is for your information and records.

Pdf Link: Marksans Pharma Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Source : BSE - www.bseindia.com

Published on March 07, 2019
This article is closed for comments.
Please Email the Editor